CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-24 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-03-17 | BARABE TIMOTHY C Director | Purchase | +5,000 | $2.00 | $10K | 88,173 |
| 2020-03-03 | Brunn Carsten President and CEO | Sale | −3,374 | $3.86 | $13K | 78,477 |
| 2020-03-01 | Brunn Carsten President and CEO | Exercise or conversion | +10,937 | 81,851 | ||
| 2020-03-01 | Brunn Carsten President and CEO | Exercise or conversion · Restricted Stock Units | −10,937 | 120,313 | ||
| 2020-01-16 | Johnston Lloyd P. COO and SVP, R&D | Exercise or conversion | +5,128 | $0.47 | $2K | 16,734 |
| 2020-01-16 | Johnston Lloyd P. COO and SVP, R&D | Exercise or conversion · Employee Stock Option (right to buy) | −5,128 | 0 | ||
| 2020-01-02 | Smolinski Stephen Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2020-01-02 | Schecter Alison D. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2020-01-02 | Kogan Elona Esq. General Counsel | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2020-01-02 | Kishimoto Takashi Kei Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2020-01-02 | Johnston Lloyd P. COO and SVP, R&D | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2020-01-02 | Dahms Bradford D. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2020-01-02 | Brunn Carsten President and CEO | Grant or award · Employee Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2019-12-23 | BARABE TIMOTHY C Director | Grant or award | +65,681 | $1.46 | $96K | 83,173 |
| 2019-12-23 | BARABE TIMOTHY C Director | Grant or award · Warrants | +32,840 | $0.13 | $4K | 32,840 |
| 2019-12-23 | SPRINGER TIMOTHY A Director | Grant or award | +3,940,887 | $1.46 | $5.8M | 5,486,463 |
| 2019-12-23 | SPRINGER TIMOTHY A Director | Grant or award · Warrants | +1,970,443 | $0.13 | $246K | 1,970,443 |
| 2019-12-23 | COX CARRIE SMITH Director | Grant or award | +65,681 | $1.46 | $96K | 65,681 |
| 2019-12-23 | COX CARRIE SMITH Director | Grant or award · Warrants | +32,840 | $0.13 | $4K | 32,840 |
Page 28 of 32 · 631 trades